|32.54||+1.11 / +3.53%|
Data as of 3:59pm ET
|32.54||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 36.00, with a high estimate of 51.00 and a low estimate of 28.00. The median estimate represents a +10.63% increase from the last price of 32.54.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.